local
system
inflamm
phagocyt
within
inflam
tissu
produc
cytokin
interleukin
interleukin
tumor
necrosi
factor
tnfa
cytokin
releas
system
circul
induc
sequela
respons
known
bacut
phase
reaction
apr
involv
differ
homeostat
system
final
aim
establish
rapid
intens
stimul
protect
respons
one
main
aspect
apr
modul
protein
synthesi
hepatocyt
ceciliani
et
al
consequ
concentr
plasma
protein
call
acut
phase
protein
app
vari
compar
basal
level
larg
major
app
posit
app
sinc
concentr
blood
increas
inflamm
bneg
app
app
whose
concentr
blood
decreas
also
exist
previous
mention
modul
protein
product
liver
depend
synerg
action
cytokin
mention
tnfa
induc
peripher
proteolysi
thu
increas
flow
aminoacid
liver
inhibit
synthesi
neg
app
stimul
synthesi
posit
app
collabor
glycocorticoid
also
produc
consequ
activ
pituitaryadren
axi
involv
releas
posit
app
hepatocyt
albumin
main
neg
app
albumin
abund
protein
blood
larg
amount
aminoacid
requir
product
apr
decreas
synthesi
albumin
increas
amount
avail
aminoacid
requir
synthesi
posit
app
neg
app
retinol
bind
protein
rbp
cortisol
bind
protein
cbp
transthyretin
ttr
transport
hormon
vitamin
transport
protein
decreas
circul
hormon
vitamin
releas
circul
sinc
bfreeform
biolog
activ
organ
thu
better
util
hormon
vitamin
without
increas
product
posit
app
includ
protein
antibacteri
immunomodul
activ
creactiv
protein
crp
complement
fraction
acid
glycoprotein
agp
lp
bind
protein
lbp
transport
protein
haptoglobin
hp
bind
hemoglobin
ceruloplasmin
cp
immunomodul
function
bind
copper
scaveng
protein
protect
tissu
potenti
danger
molecul
serum
amyloid
saa
aglobulin
antiproteas
activ
posit
app
fibrinogen
show
moder
increas
inflamm
app
hp
agp
increas
time
compar
basal
level
amd
other
saa
increas
time
dog
cat
bmajoracut
phase
protein
increas
frequent
thu
marker
choic
diagnosi
crp
agp
respect
app
migrat
within
aglobulin
serum
protein
electrophoresi
may
indic
occurr
apr
contrast
colorimetr
immunolog
elisa
immunoturbidimetri
radial
immunodiffus
method
requir
measur
singl
app
method
creat
problem
sinc
speciesspecif
antifelin
anticanin
antibodi
rare
avail
expens
avail
app
product
rapid
take
hour
detect
intens
specif
given
diseas
mention
cytokin
fact
induc
inflammatori
stimulu
independ
type
sever
even
non
inflammatori
stimuli
tumour
pathophysiolog
condit
stress
pregnanc
lack
specif
repres
signific
limit
bypass
demonstr
also
advantag
diagnost
point
view
sinc
increas
protein
mean
organ
combat
potenti
danger
event
basic
measur
posit
app
opposit
role
serolog
bacteriolog
clinic
patholog
techniqu
demonstr
specif
pathogen
encount
organ
andor
damag
system
apparatu
eg
caus
anemia
renal
failur
etc
contrari
high
app
level
help
us
understand
pathogen
present
demonstr
organ
still
fight
pathogen
basi
human
medicin
measur
app
level
gain
role
prognost
clinic
decis
make
marker
app
also
use
diagnosi
specif
diseas
alreadi
obtain
routin
clinic
clinicopatholog
approach
establish
whether
observ
chang
sequela
hostpathogen
interact
app
level
like
low
organ
still
respond
potenti
pathogen
app
level
would
high
might
necessari
chang
modul
therapeut
approach
also
human
medicin
app
use
followup
monitor
respons
therapi
treatment
effect
app
return
baselin
valu
rapidli
indic
diseas
regress
final
app
may
also
induc
diseas
exampl
saa
produc
non
specif
inflamm
extravas
blood
tissu
remov
oxid
lipid
proteol
tissu
enzym
inflamm
persist
saa
satur
tissu
proteolyt
enzym
partial
proteolys
saa
assum
bsheet
conform
accumul
tissu
amyloid
reactiv
system
amyloidosi
similarli
saa
fibril
accumul
tissu
hereditari
amyloidosi
sharpei
dog
orient
abyssinian
somali
cat
amyloidogen
saa
sequenc
complet
proteolyz
reactiv
system
hereditari
amyloidosi
monitor
measur
serum
saa
main
limit
app
measur
poor
diagnost
specif
mention
rel
high
cost
per
test
latter
aspect
probabl
bypass
futur
sinc
sever
paper
kjlelgaardhansen
et
al
exampl
valid
autom
method
would
decreas
cost
per
test
allow
simultan
process
numer
sampl
regard
poor
diagnost
specif
futur
studi
would
defin
optim
cutoff
discrimin
anim
inflamm
diseas
inflamm
regard
app
measur
dog
sever
studi
reveal
role
app
marker
inflamm
level
singl
app
specif
disord
gener
speak
blood
level
major
app
dog
crp
saa
lesser
extent
hp
cp
much
elev
dog
inflamm
even
non
specif
induc
surgeri
dog
tumour
degen
immunemedi
disord
conner
et
al
solter
et
al
ogilvi
et
al
hayashi
et
al
martinezsubiela
et
al
fransson
et
al
tecl
et
al
moreov
app
use
prognost
monitor
purpos
exampl
dog
canin
babesiosi
diagnos
convent
hematolog
approach
higher
app
level
complic
present
lobetti
et
al
similarli
crp
agp
level
increas
presymptomat
phase
erlichiosi
leishmaniasi
rikihisa
et
al
martinezsubiela
et
al
moreov
canin
app
level
decreas
earli
appropri
treatment
independ
type
diseas
remain
elev
bpoor
respond
lobetti
et
al
tecl
et
al
confirm
role
app
treatment
monitor
dog
final
app
level
influenc
vaccin
steroid
barbitur
therapi
pregnanc
eckersal
et
al
hojo
et
al
martinezsubiela
et
al
situat
thu
possibl
bfals
positiveincreas
app
data
regard
app
level
cat
scarc
demonstr
agp
hp
saa
increas
hour
inflamm
surgeri
independ
presenc
possibl
postsurg
complic
kajikawa
et
al
saa
level
increas
also
renal
failur
neoplasm
liver
disord
sasaki
et
al
similarli
agp
increas
cat
lymphoma
selt
et
al
studi
felin
agp
regard
felin
infecti
periton
fip
lethal
diseas
difficult
diagnos
convent
approach
agp
increas
fip
evid
diagnost
diseas
duthi
et
al
nevertheless
demonstr
nonsymptomat
shedder
felin
coronaviru
viru
respons
fip
also
exhibit
cyclic
fluctuat
serum
agp
level
like
due
continu
reinfect
giordano
et
al
base
find
agp
level
interpret
caution
cat
live
endem
catteri
